-+ 0.00%
-+ 0.00%
-+ 0.00%

AlzChem nine-month EBITDA rises 8% to EUR 93.2 million

PUBT·10/29/2026 05:56:25
Listen to the news
AlzChem nine-month EBITDA rises 8% to EUR 93.2 million
  • Alzchem's nine-month 2026 EBITDA rose 8% to EUR 93.2 million; sales increased to EUR 443.8 million.
  • Specialty Chemicals EBITDA climbed 17% to EUR 91.5 million, while segment sales grew 11% to EUR 312.7 million.
  • Technical commissioning of additional German guanidine nitrate and nitroguanidine capacity began in the third quarter; first sales are expected in fourth-quarter 2026.
  • Management confirmed its 2026 outlook for sales of approximately EUR 600 million and EBITDA of around EUR 126 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzChem Group AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2423918_en) on October 29, 2026, and is solely responsible for the information contained therein.